News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
230 Results
Type
Article (16)
Press Release (214)
Section
Business (74)
Deals (7)
Drug Development (61)
FDA (3)
Job Trends (3)
News (117)
Policy (3)
Tag
Academia (3)
Alliances (4)
Alzheimer's disease (19)
Approvals (3)
Best Places to Work (3)
Cardiovascular disease (2)
Cell therapy (5)
Clinical research (51)
COVID-19 (4)
C-suite (2)
Data (7)
Diagnostics (2)
Drug discovery (1)
Earnings (41)
Events (74)
Executive appointments (2)
FDA (9)
Gene therapy (1)
GLP-1 (3)
Healthcare (1)
Infectious disease (4)
Intellectual property (1)
IPO (8)
Medical device (1)
Medtech (1)
Neurodegenerative disease (3)
Neuroscience (19)
NextGen: Class of 2026 (15)
Opinion (1)
Patents (3)
People (29)
Phase 1 (21)
Phase 2 (41)
Phase 3 (6)
Pipeline (9)
Regulatory (8)
Research institute (3)
Startups (1)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (36)
2026 (3)
2025 (34)
2024 (46)
2023 (34)
2022 (37)
2021 (49)
2020 (1)
2019 (6)
2018 (13)
2017 (7)
Location
Asia (4)
California (1)
Europe (6)
Florida (60)
Japan (1)
New York (1)
Pennsylvania (1)
Southern California (1)
United States (62)
230 Results for "longeveron".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
January 29, 2026
·
7 min read
Press Releases
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
February 5, 2026
·
8 min read
Press Releases
Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
January 27, 2026
·
6 min read
Press Releases
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026
December 29, 2025
·
5 min read
Press Releases
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
November 4, 2025
·
16 min read
Press Releases
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum
December 4, 2025
·
2 min read
Press Releases
Longeveron® Announces Key Leadership Updates
September 4, 2025
·
9 min read
Press Releases
Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
October 7, 2025
·
1 min read
Press Releases
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
October 29, 2025
·
1 min read
Press Releases
Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging
December 3, 2025
·
7 min read
1 of 23
Next
